FCG Investment Co Increases Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

FCG Investment Co increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 9.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,362 shares of the medical equipment provider’s stock after buying an additional 212 shares during the period. FCG Investment Co’s holdings in Intuitive Surgical were worth $1,233,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of ISRG. Galvin Gaustad & Stein LLC purchased a new position in Intuitive Surgical during the 4th quarter valued at about $218,000. Raleigh Capital Management Inc. grew its stake in Intuitive Surgical by 8.2% during the fourth quarter. Raleigh Capital Management Inc. now owns 318 shares of the medical equipment provider’s stock valued at $166,000 after acquiring an additional 24 shares in the last quarter. True North Advisors LLC grew its stake in Intuitive Surgical by 41.6% during the fourth quarter. True North Advisors LLC now owns 1,744 shares of the medical equipment provider’s stock valued at $910,000 after acquiring an additional 512 shares in the last quarter. Traynor Capital Management Inc. increased its holdings in Intuitive Surgical by 13.1% during the 4th quarter. Traynor Capital Management Inc. now owns 41,134 shares of the medical equipment provider’s stock worth $21,470,000 after acquiring an additional 4,771 shares during the period. Finally, Wesbanco Bank Inc. lifted its stake in Intuitive Surgical by 1.6% in the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock worth $635,000 after purchasing an additional 19 shares in the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Intuitive Surgical

In related news, EVP Robert Desantis sold 188 shares of the business’s stock in a transaction dated Tuesday, October 29th. The stock was sold at an average price of $506.52, for a total transaction of $95,225.76. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,788,899.12. The trade was a 3.30 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Gary S. Guthart sold 18,151 shares of the stock in a transaction that occurred on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the sale, the chief executive officer now owns 24,219 shares of the company’s stock, valued at approximately $12,391,166.97. This trade represents a 42.84 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 42,475 shares of company stock worth $22,070,807. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Price Performance

ISRG opened at $608.66 on Friday. The stock’s 50 day simple moving average is $544.61 and its 200 day simple moving average is $502.64. The firm has a market cap of $216.79 billion, a price-to-earnings ratio of 97.86, a PEG ratio of 5.13 and a beta of 1.39. Intuitive Surgical, Inc. has a 1 year low of $362.14 and a 1 year high of $616.00.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of recent analyst reports. The Goldman Sachs Group set a $604.00 price target on shares of Intuitive Surgical in a research report on Friday, October 18th. Robert W. Baird boosted their target price on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research report on Thursday, October 17th. JPMorgan Chase & Co. raised their price target on Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a report on Friday, October 11th. Leerink Partners boosted their price objective on Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. Finally, Wells Fargo & Company raised their target price on shares of Intuitive Surgical from $549.00 to $630.00 and gave the company an “overweight” rating in a research note on Wednesday, December 11th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $554.17.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.